M&A Deal Summary |
|
---|---|
Date | 2015-08-20 |
Target | Bio-Reference Laboratories |
Sector | Life Science |
Buyer(s) | Opko |
Deal Type | Add-on Acquisition |
Deal Value | 1.5B USD |
Advisor(s) | Allen & Company (Financial) Davis Polk & Wardwell (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1991 |
Sector | Life Science |
Employees | 5,269 |
Revenue | 1.0B USD (2022) |
Opko is a diversified healthcare company that seeks to establish industry-leading positions in large and rapidly growing medical markets. Opko's diagnostics business includes Bio-Reference Laboratories, a clinical laboratory with a core genetic testing business and a 420-person salesforce to drive growth and leverage new products, including the 4Kscore prostate cancer test and the Claros 1 in-office immunoassay platform. Opko's pharmaceutical business includes Rayaldee, a treatment for secondary hyperparathyroidism in patients with stage 3 or 4 chronic kidney disease and vitamin D insufficiency and VARUBI for chemotherapy-induced nausea and vomiting. Opko's pharmaceutical business also includes OPKO Biologics, which features hGH-CTP, a once-weekly human growth hormone injection and a longer acting Factor VIIa drug for hemophilia. Opko was founded in 1991 and is based in Miami, Florida.
DEAL STATS | # |
---|---|
Overall | 18 of 20 |
Sector (Life Science) | 7 of 9 |
Type (Add-on Acquisition) | 16 of 18 |
State (New Jersey) | 1 of 1 |
Country (United States) | 6 of 7 |
Year (2015) | 2 of 2 |
Size (of disclosed) | 1 of 6 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-05-05 |
EirGen Pharma
Waterford, Ireland EirGen Pharma Ltd. is a specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-06-30 |
Transition Therapeutics
Toronto, Ontario, Canada Transition Therapeutics Inc. is a bio pharmaceutical company, develops therapeutics for various disease indications. Transition Therapeutics, Inc. was formed in 1987 and is based in Toronto, Ontario. |
Buy | $60M |